Starling Oncology (STLNW) Cash & Equivalents Growth (1y) (2020 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Cash & Equivalents Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | -5.57% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | -12.83% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | -36.65% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 113.93% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 5.66% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | 28.54% |
| 7 | Progyny | 2.12 Bn | 1.89 Bn | 89.30 Mn | 15.19% |
| 8 | Surgery Partners | 1.82 Bn | 1.61 Bn | 622.10 Mn | -13.35% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.14 Bn | 41.94 Mn | -26.99% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 35.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.66% |
| Mar 31, 2026 | -23.80% |
| Dec 31, 2025 | -32.42% |
| Sep 30, 2025 | -41.65% |
| Jun 30, 2025 | -16.84% |
| Mar 31, 2025 | 10.22% |
| Dec 31, 2024 | 48.32% |
| Sep 30, 2024 | 72.15% |
| Jun 30, 2024 | 26.07% |
| Mar 31, 2024 | 136.43% |
| Dec 31, 2023 | 139.03% |
| Sep 30, 2023 | -55.17% |
| Jun 30, 2023 | -55.00% |
| Mar 31, 2023 | -84.04% |
| Dec 31, 2022 | -87.84% |
| Sep 30, 2022 | 432.65% |
| Jun 30, 2022 | 323.28% |
| Mar 31, 2022 | 248.51% |
| Dec 31, 2021 | 1,820.21% |
| Sep 30, 2021 | 1,054.85% |